Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
6.63
+0.11 (1.69%)
Jan 7, 2026, 4:00 PM EST - Market closed
Myriad Genetics Employees
Myriad Genetics had 2,700 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,700
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$305,667
Profits / Employee
-$148,333
Market Cap
618.01M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,700 | 0 | - |
| Dec 31, 2023 | 2,700 | 100 | 3.85% |
| Dec 31, 2022 | 2,600 | 200 | 8.33% |
| Dec 31, 2021 | 2,400 | -300 | -11.11% |
| Dec 31, 2020 | 2,700 | 0 | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MYGN News
- 2 days ago - Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health - GlobeNewsWire
- 2 months ago - Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - GlobeNewsWire
- 2 months ago - Myriad Genetics: Downgrading To "Hold" Rating On Break-Even Q3 Earnings - Seeking Alpha
- 2 months ago - Myriad Genetics, Inc. (MYGN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution - GlobeNewsWire
- 2 months ago - New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner - GlobeNewsWire
- 2 months ago - Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025 - GlobeNewsWire